Colin Meyer
Keine laufenden Positionen mehr
Karriereverlauf von Colin Meyer
Ehemalige bekannte Positionen von Colin Meyer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 10.09.2013 | 07.02.2022 |
| Corporate Officer/Principal | 07.02.2022 | 26.09.2023 |
Ausbildung von Colin Meyer
| University of Virginia | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| SMU-Cox School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Börse
- Insiders
- Colin Meyer
- Erfahrung
